$BCPC

BCPC Q3'26 Earnings: revenue estimate is 289.25M USD

Balchem Corporation (BCPC) is scheduled to release its Q3'26 earnings on October 23. Analysts expect revenue of 289.25M USD and EPS of 1.43 USD. The results will be announced before the market opens at 9:30 AM ET.

Original reporting
Published Oct 16, 2026, 11:00 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 16, 2026, 11:04 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
BCPC Q3'26 Earnings: revenue estimate is 289.25M USD — source image
Decision brief

The 30-second read

$BCPCNeutralMed
01

Why it matters

The disclosed revenue and EPS forecasts set market expectations and may trigger pre‑release positioning.

02

Market read

The estimate provides new data for traders to gauge BCPC's upcoming earnings performance.

03

What to watch

Potential supply‑chain or raw‑material cost pressures not reflected in the estimate.

Relevance 5/10Novelty 5/10Timing: pre‑market on Oct 23

Background

Balchem Corp. (BCPC) is a mid‑cap specialty chemicals company. The article announces its upcoming Q3'26 earnings estimate.

Company-level read

Ticker impact

$BCPCNeutralHigh confidence
Context

Balchem Corp. will release Q3'26 earnings on Oct 23 with revenue estimate $289.25M and EPS $1.43.

Expected impact

potential volatility around the release as traders position on the forecast.

Evidence & confidence

The article provides the first public estimate for the upcoming quarter, a key data point for short‑term traders.

Market effects

Balchem's guidance may influence sentiment in the specialty chemicals sector.

U.S. market participants will watch the release for broader earnings trends.

Limited to investors tracking U.S. mid‑cap earnings.

Counterpoint

If the actual results miss the estimate, the stock could see a sharp sell‑off.

Key entities

  • Balchem Corporation

    U.S. listed specialty chemicals manufacturer.

Related articles

$BCPCMed

Balchem Corporation Reports Second Quarter 2026 Financial Results

BALCHEM CORP (BCPC) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Human Nutrition & Health | Animal Nutrition & Health | Specialty Products Balchem Corporation Reports Second Quarter 2026 Financial Results Montvale, NJ, July 31, 2026 - Balchem Corporation (NASDAQ: BCPC) today reported financial results for its 2026 fiscal second qu

$ZIONMed

Zions Bancorporation Q3 Earnings Improve

Zions Bancorporation reported Q3 2026 earnings per share rose 20% to $1.78, driven by improved credit quality. Net income increased to $262M from $221M YoY. Non-interest income and net interest income also grew, while total interest income declined slightly.

$IBNMedAI 8/10

How ICICI Bank Is Driving Loan Growth and Managing Risk?

ICICI Bank reported Q2 FY27 results with net interest income up 17.6% YoY and 4% QoQ, and net profit up 21% YoY and 6.8% QoQ. Loans grew 30% YoY, deposits rose 27.1% YoY, and bad loans declined. The bank's shares trade at a 6.4% discount to their 52-week high, with a P/E of 16.8.

HighAI 8/10

Buy ICICI Bank Ltd for the Target Rs.1,750 by Motilal Oswal Financial Services Ltd

ICICI Bank (ICICIBC) reported 2QFY27 PAT of INR148.4b, in line with expectations, driven by strong loan growth and controlled provisions. NIMs declined 18bp QoQ to 4.18%, but are expected to improve from 4QFY27. The bank raised its earnings estimate for FY28, with a target price of INR1,750. ICICIBC maintains strong asset quality and robust business growth, according to Motilal Oswal.